Metastatic Colorectal Cancers Recruiting Phase 1 Trials for Nivolumab (DB09035)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03712943Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal CancerTreatment